Encompass Health Corp Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Encompass Health Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
  • Encompass Health Corp Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $38.3M, a 16.8% increase year-over-year.
  • Encompass Health Corp Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $144M, a 21.7% increase year-over-year.
  • Encompass Health Corp annual Income Tax Expense (Benefit) for 2023 was $132M, a 32.1% increase from 2022.
  • Encompass Health Corp annual Income Tax Expense (Benefit) for 2022 was $100M, a 1.77% decline from 2021.
  • Encompass Health Corp annual Income Tax Expense (Benefit) for 2021 was $102M, a 36.4% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $144M $38.3M +$5.5M +16.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $139M $38.3M +$6.4M +20.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $132M $37.2M +$5.3M +16.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $127M $30.3M +$8.5M +39% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $118M $32.8M +$10M +43.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $108M $31.9M +$8.3M +35.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $100M $31.9M +$9.4M +41.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $90.7M $21.8M -$4.4M -16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $95.1M $22.8M -$5.4M -19.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $101M $23.6M -$1.4M -5.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $102M $22.5M -$15.5M -40.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 $117M $26.2M -$700K -2.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-27
Q2 2021 $118M $28.2M +$16.4M +139% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-27
Q1 2021 $102M $25M -$2.1M -7.75% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-27
Q4 2020 $104M $38M +$10.7M +39.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 $93.1M $26.9M -$7.4M -21.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $101M $11.8M -$11.7M -49.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $112M $27.1M -$3.7M -12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $116M $27.3M -$2.1M -7.14% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $118M $34.3M +$4.1M +13.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 $114M $23.5M -$5.8M -19.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 $120M $30.8M +$800K +2.67% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 $119M $29.4M -$5M -14.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $124M $30.2M -$12.9M -29.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $137M $29.3M +$700K +2.45% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $136M $30M -$9.7M -24.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $146M $34.4M -$5.3M -13.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $151M $43.1M +$1M +2.38% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $150M $28.6M -$13.8M -32.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 $164M $39.7M $0 0% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $164M $39.7M -$3.8M -8.74% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $168M $42.1M +$6.2M +17.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $162M $42.4M +$10.2M +31.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 $151M $39.7M +$9.4M +31% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 $142M $43.5M +$24.2M +125% Oct 1, 2015 Dec 31, 2015 8-K 2017-09-19
Q3 2015 $118M $35.9M +$13.8M +62.4% Jul 1, 2015 Sep 30, 2015 8-K 2017-09-19
Q2 2015 $104M $32.2M -$4.3M -11.8% Apr 1, 2015 Jun 30, 2015 8-K 2017-09-19
Q1 2015 $108M $30.3M -$2.5M -7.62% Jan 1, 2015 Mar 31, 2015 8-K 2017-09-19
Q4 2014 $111M $19.3M -$11.2M -36.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $122M $22.1M -$13.1M -37.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $135M $36.5M +$123M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $12M $32.8M -$700K -2.09% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 $12.7M $30.5M +$6M +24.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 $6.7M $35.2M +$7.1M +25.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 -$400K -$86.5M -$113M -422% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 $113M $33.5M +$4.4M +15.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 $109M $24.5M +$9.3M +61.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-20
Q3 2012 $99.3M $28.1M +$10M +55.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-20
Q2 2012 $89.3M $26.9M +$15.7M +140% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-20
Q1 2012 $73.6M $29.1M +$36.5M Jan 1, 2012 Mar 31, 2012 10-K 2014-02-20
Q4 2011 $37.1M $15.2M +$757M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-19
Q3 2011 -$720M $18.1M +$18.5M Jul 1, 2011 Sep 30, 2011 10-K 2013-02-19
Q2 2011 -$738M $11.2M +$12.5M Apr 1, 2011 Jun 30, 2011 10-K 2013-02-19
Q1 2011 -$751M -$7.4M -$9.8M -408% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-19
Q4 2010 -$741M -$742M Oct 1, 2010 Dec 31, 2010 8-K 2012-09-06
Q3 2010 -$400K Jul 1, 2010 Sep 30, 2010 8-K 2012-09-06
Q2 2010 -$1.3M Apr 1, 2010 Jun 30, 2010 8-K 2012-09-06
Q1 2010 $2.4M Jan 1, 2010 Mar 31, 2010 8-K 2012-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.